Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with profound effects on multiple organ systems. In patients with SLE, the immune system is subverted to target numerous self antigens and the ensuing inflammatory response elicits a vicious cycle of immune-cell activation and tissue damage. Both genetic and environmental factors are essential for the development of this debilitating condition, although the exact cause remains unclear. Early studies on the pathogenesis of lupus centered on the adaptive immune system as lymphocyte abnormalities were thought to be the primary cause of autoimmunity. In the past decade, however, this paradigm has shifted with rapid advances in the field of innate immunity. These developments have yielded important insights into how the autoimmune response in SLE is initiated and maintained. Monocytes and macrophages are an essential arm of the innate immune system with a multitude of immunological functions, including antigen presentation, phagocytosis, and cytokine production. Aberrations of monocyte/macrophage phenotype and function are increasingly recognized in SLE and animal models of the disease. In this review we summarize the current knowledge of monocyte/macrophage abnormalities in human SLE and discuss their implications for understanding the pathogenesis of lupus.
Similar content being viewed by others
Abbreviations
- SLE:
-
Systemic lupus erythematosus
- DC:
-
Dendritic cell
- PAMPs:
-
Pathogen-associated molecular patterns
- TLR:
-
Toll-like receptor
- MHC:
-
Major histocompatibility complex
- FcγR:
-
Fc gamma receptor
- ICAM-1:
-
Intercellular adhesion molecule-1
- IFN-1:
-
Type-1 interferon
- ISG:
-
Interferon-stimulated gene
- Th:
-
T helper
- BLyS:
-
B lymphocyte stimulator
- RA:
-
Rheumatoid arthritis
- HSC:
-
Hematopoietic stem cell
References
Aderem A, Underhill DM (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17:593–623
A-Gonzalez N, Bensinger SJ, Hong C et al (2009) Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31:245–258
Aitman TJ, Dong R, Vyse TJ et al (2006) Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439:851–855
Akiyama Y, Miller PJ, Thurman GB et al (1983) Characterization of a human blood monocyte subset with low peroxidase activity. J Clin Invest 72:1093–1105
Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967
Auffray C, Sieweke MH, Geissmann F (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 27:669–692
Baechler EC, Batliwalla FM, Karypis G et al (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 100:2610–2615
Banchereau J, Bazan F, Blanchard D et al (1994) The CD40 antigen and its ligand. Annu Rev Immunol 12:881–922
Barrat FJ, Meeker T, Gregorio J et al (2005) Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202:1131–1139
Barton GM, Kagan JC, Medzhitov R et al (2006) Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7:49–56
Bauer JW, Baechler EC, Petri M et al (2006) Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med 3:e491
Baumann I, Kolowos W, Voll RE et al (2002) Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46:191–201
Bengtsson AA, Sturfelt G, Gullstrand B et al (2004) Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus––an additional mechanism to increased autoantigen load? Clin Exp Immunol 135:535–543
Bennett L, Palucka AK, Arce E et al (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197:711–723
Bergtold A, Gavhane A, D’Agati V et al (2006) FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J Immunol 177:7287–7295
Berland R, Fernandez L, Kari E et al (2006) Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity 25:429–440
Biesen R, Demir C, Barkhudarova F et al (2008) Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis Rheum 58:1136–1145
Bijl M, Reefman E, Horst G et al (2006) Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Ann Rheum Dis 65:57–63
Birge RB, Ucker DS (2008) Innate apoptotic immunity: the calming touch of death. Cell Death Differ 15:1096–1102
Blanco P, Palucka AK, Gill M et al (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294:1540–1543
Blank MC, Stefanescu RN, Masuda E et al (2005) Decreased transcription of the human FCGR2B gene mediated by the −343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet 117:220–227
Bolland S, Yim YS, Tus K et al (2002) Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(−/−) mice. J Exp Med 195:1167–1174
Cairns AP, Crockard AD, McConnell JR et al (2001) Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity. Ann Rheum Dis 60:950–955
Cairns AP, Crockard AD, Bell AL (2002) The CD14+ CD16+ monocyte subset in rheumatoid arthritis and systemic lupus erythematosus. Rheumatol Int 21:189–192
Carroll MC (1998) The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 16:545–568
Cavassani KA, Ishii M, Wen H et al (2008) TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J Exp Med 205:2609–2621
Chung EY, Kim SJ, Ma XJ (2006) Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res 16:154–161
Clynes R, Dumitru C, Ravetch JV et al (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279:1052–1054
Coremans IE, Spronk PE, Bootsma H et al (1995) Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 26:595–601
Decker P, Kotter I, Klein R et al (2006) Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology 45:1087–1095
Desai-Mehta A, Lu L, Ramsey-Goldman R et al (1996) Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97:2063–2073
Devitt A, Moffatt OD, Raykundalia C et al (1998) Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392:505–509
Ding D, Mehta H, McCune WJ et al (2006) Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol 177:5878–5889
Dykman TR, Hatch JA, Atkinson JP (1984) Polymorphism of the human C3b/C4b receptor. Identification of a third allele and analysis of receptor phenotypes in families and patients with systemic lupus erythematosus. J Exp Med 159:691–703
Fadok VA, Savill JS, Haslett C et al (1992) Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 149:4029–4035
Fadok VA, Bratton DL, Konowal A et al (1998a) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101:890–898
Fadok VA, Warner ML, Bratton DL et al (1998b) CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3). J Immunol 161:6250–6257
Fadok VA, Bratton DL, Henson PM (2001) Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 108:957–962
Fanciulli M, Norsworthy PJ, Petretto E et al (2007) FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 39:721–723
Farkas L, Beiske K, Lund-Johansen F et al (2001) Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 159:237–243
Figdor CG, Bont WS, Touw I et al (1982) Isolation of functionally different human monocytes by counterflow centrifugation elutriation. Blood 60:46–53
Floto RA, Clatworthy MR, Heilbronn KR et al (2005) Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat Med 11:1056–1058
Funauchi M, Ohno M, Minoda M et al (1993) Abnormal expression of intercellular adhesion molecule-1 on peripheral blood mononuclear cells from patients with systemic lupus erythematosus. J Clin Lab Immunol 40:115–124
Gaipl US, Voll RE, Sheriff A et al (2005) Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev 4:189–194
Gorden KB, Gorski KS, Gibson SJ et al (2005) Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 174:1259–1268
Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964
Grage-Griebenow E, Flad HD, Ernst M (2001a) Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 69:11–20
Grage-Griebenow E, Zawatzky R, Kahlert H et al (2001b) Identification of a novel dendritic cell-like subset of CD64(+)/CD16(+) blood monocytes. Eur J Immunol 31:48–56
Grevink ME, Horst G, Limburg PC et al (2005) Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cells. J Autoimmun 24:329–336
Grossmayer GE, Munoz LE, Weber CK et al (2008) IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera. Ann Rheum Dis 67:1626–1632
Hagiwara E, Gourley MF, Lee S et al (1996) Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum 39:379–385
Hanai H, Watanabe F, Yamada M et al (2004) Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis. Am J Gastroenterol 99:1532–1538
Hanh BH (2005) Systemic Lupus Erythematosus. In: Kasper DL (ed) Harrison’s principles of internal medicine. McGraw-Hill, New York, pp 1956–1967
Hepburn AL, Mason JC, Davies KA (2004) Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology 43:547–554
Herrmann M, Voll RE, Zoller OM et al (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41:1241–1250
Hoffmann PR, deCathelineau AM, Ogden CA et al (2001) Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 155:649–659
Hornung V, Rothenfusser S, Britsch S et al (2002) Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531–4537
Houssiau FA, Mascart-Lemone F, Stevens M et al (1997) IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC). Clin Exp Immunol 108:375–380
Iyer SS, Pulskens WP, Sadler JJ et al (2009) Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 106:20388–20393
Jego G, Palucka AK, Blanck JP et al (2003) Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19:225–234
Karonitsch T, Feierl E, Steiner CW et al (2009) Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells. Arthritis Rheum 60:1463–1471
Katsiari CG, Liossis SN, Souliotis VL et al (2002) Aberrant expression of the costimulatory molecule CD40 ligand on monocytes from patients with systemic lupus erythematosus. Clin Immunol 103:54–62
Katsiari CG, Liossis SN, Sfikakis PP et al (2010) The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. Semin Arthritis Rheum 39:491–503
Kavai M, Szegedi G (2007) Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus. Autoimmun Rev 6:497–502
Kawanaka N, Yamamura M, Aita T et al (2002) CD14+, CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 46:2578–2586
Kelly KM, Zhuang H, Nacionales DC et al (2006) “Endogenous adjuvant” activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60. Arthritis Rheum 54:1557–1567
Klinman DM, Takeshita F, Gursel I et al (2002) CpG DNA: recognition by and activation of monocytes. Microbes Infect 4:897–901
Koshy M, Berger D, Crow MK (1996) Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98:826–837
Kyttaris VC, Juang YT, Tsokos GC (2005) Immune cells and cytokines in systemic lupus erythematosus: an update. Curr Opin Rheumatol 17:518–522
Lee PY, Li Y, Richards HB et al (2007) Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum 56:3759–3769
Lee PY, Kumagai Y, Li Y et al (2008) TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med 205:2995–3006
Lee PY, Li Y, Kumagai Y et al (2009) Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am J Pathol 175:2023–2033
Lee-Kirsch MA, Gong M, Chowdhury D et al (2007) Mutations in the gene encoding the 3′-5″ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39:1065–1067
Li H, Ambade A, Re F (2009a) Cutting edge: necrosis activates the NLRP3 inflammasome. J Immunol 183:1528–1532
Li X, Ptacek TS, Brown EE et al (2009b) Fcgamma receptors: structure, function and role as genetic risk factors in SLE. Genes Immunol 10:380–389
Li Y, Lee PY, Sobel ES et al (2009c) Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus. Arthritis Res Ther 11:R6
Li Y, Lee PY, Kellner ES et al (2010d) Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus. Arthritis Res Ther 12(3):R90
Liao CH, Yao TC, Chung HT et al (2004) Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. J Rheumatol 31:2062–2067
Linker-Israeli M, Deans RJ, Wallace DJ et al (1991) Elevated level of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147:117–123
Liu TF, Jones BM (1998) Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes. Cytokine 10:140–147
Llorente L, Richaud-Patin Y, Wijdenes J et al (1993) Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 4:421–427
Mackay M, Stanevsky A, Wang T et al (2006) Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med 203:2157–2164
Manderson AP, Botto M, Walport MJ (2004) The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22:431–456
Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6:823–835
Mellor-Pita S, Citores MJ, Castejon R et al (2009) Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Cytometry B Clin Cytom 76B:261–270
Mevorach D, Mascarenhas JO, Gershov DD et al (1998) Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188:2313–2320
Moore PA, Belvedere O, Orr A et al (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285:260–263
Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958–969
Munoz LE, Janko C, Grossmayer GE et al (2009) Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum 60:1733–1742
Nardelli B, Belvedere O, Roschke V et al (2001) Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97:198–204
Nimmerjahn F, Ravetch JV (2008) Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 8:34–47
Papadaki HA, Boumpas DT, Gibson FM et al (2001) Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol 115:167–174
Passlick B, Flieger D, Ziegler-Heitbrock HW (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74:2527–2534
Peterson KS, Huang JF, Zhu J et al (2004) Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest 113:1722–1733
Reefman E, Horst G, Nijk MT et al (2007) Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism. Arthritis Rheum 56:3399–3411
Reeves WH, Narain S, Satoh M (2004) Autoantibodies in systemic lupus erythematosus. Lippincott Williams & Wilkins, Philadelphia
Ren Y, Tang J, Mok MY et al (2003) Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 48:2888–2897
Scott RS, McMahon EJ, Pop SM et al (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411:207–211
Sharif MN, Tassiulas I, Hu Y et al (2004) IFN-alpha priming results in a gain of proinflammatory function by IL-10: implications for systemic lupus erythematosus pathogenesis. J Immunol 172:6476–6481
Shirakawa F, Yamashita U, Suzuki H (1985) Reduced function of HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE). J Clin Immunol 5:396–403
Shoshan Y, Shapira I, Toubi E et al (2001) Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells. J Immunol 167:5963–5969
Skrzeczynska J, Kobylarz K, Hartwich Z et al (2002) CD14+ CD16+ monocytes in the course of sepsis in neonates and small children: monitoring and functional studies. Scand J Immunol 55:629–638
Skrzeczynska-Moncznik J, Bzowska M, Loseke S et al (2008) Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol 67:152–159
Steinbach F, Henke F, Krause B et al (2000) Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility. Ann Rheum Dis 59:283–288
Su K, Yang H, Li X et al (2007) Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. J Immunol 178:3272–3280
Sumegi A, Antal-Szalmas P, Aleksza M et al (2005) Glucocorticosteroid therapy decreases CD14-expression and CD14-mediated LPS-binding and activation of monocytes in patients suffering from systemic lupus erythematosus. Clin Immunol 117:271–279
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376
Tas SW, Quartier P, Botto M et al (2006) Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis 65:216–221
Theofilopoulos AN, Baccala R, Beutler B et al (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307–336
Tsokos GC, Kovacs B, Sfikakis PP et al (1996) Defective antigen-presenting cell function in patients with systemic lupus erythematosus. Arthritis Rheum 39:600–609
Unanue ER (1978) The regulation of lymphocyte functions by the macrophage. Immunol Rev 40:227–255
Uwatoko S, Aotsuka S, Okawa M et al (1984) Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol 30:104–116
Vollmer J, Tluk S, Schmitz C et al (2005) Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 202:1575–1585
Wermeling F, Chen Y, Pikkarainen T et al (2007) Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus. J Exp Med 204:2259–2265
Wijngaarden S, van Roon JA, Bijlsma JW et al (2003) Fcgamma receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs. Rheumatology 42:681–688
Yang Y, Chung EK, Wu YL et al (2007) Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 80:1037–1054
York MR, Nagai T, Mangini AJ et al (2007) A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and Toll-like receptor agonists. Arthritis Rheum 56:1010–1020
Zhang J, Roschke V, Baker KP et al (2001) Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol 166:6–10
Ziegler-Heitbrock HW (1996) Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. Immunol Today 17:424–428
Ziegler-Heitbrock HW, Passlick B, Flieger D (1988) The monoclonal antimonocyte antibody My4 stains B lymphocytes and two distinct monocyte subsets in human peripheral blood. Hybridoma 7:521–527
Acknowledgments
This work was supported by R01-AR44731 from the US Public Health Service and by generous gifts from Lupus Link, Inc. (Daytona Beach, FL) and Mr. Lewis M. Schott to the UF Center for Autoimmune Disease.
Author information
Authors and Affiliations
Corresponding author
Additional information
Y. Li and P. Y. Lee contributed equally to this work.
About this article
Cite this article
Li, Y., Lee, P.Y. & Reeves, W.H. Monocyte and Macrophage Abnormalities in Systemic Lupus Erythematosus. Arch. Immunol. Ther. Exp. 58, 355–364 (2010). https://doi.org/10.1007/s00005-010-0093-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-010-0093-y